Actively Recruiting
Effectiveness of Serratus Posterior Superior Intercostal Plane Block Applied With Ultrasonography in Myofascial Pain Syndrome
Led by Halil Ibrahim Altun · Updated on 2024-08-16
100
Participants Needed
1
Research Sites
6 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the effectiveness of a new ultrasound-guided treatment called the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) for Myofascial Pain Syndrome (MAS), a condition causing muscle pain and tension due to trigger points. MAS often affects young people and desk workers. This observational study compares SPSIPB with the traditional trigger point injection method to understand which provides better relief. The study was conducted at the Algology Department of Kanuni Sultan Süleyman Training and Research Hospital between March 2023 and March 2024. The SPSIPB targets the serratus posterior superior muscle located under the rhomboid muscles, using ultrasound guidance to deliver the block from a single injection point. The traditional treatment involves trigger point injections to relax tense muscle bands. Both treatments are applied once to the neck and back region. The study collects data retrospectively from patients aged 18 to 65 who received either SPSIPB or trigger point injections during this period. Participants' records are reviewed for age, gender, pain levels measured by Visual Analog Scale (VAS), neck disability scores, and muscle sensitivity before treatment and at one and three months after the procedure. The main outcome is the timing and onset of pain relief measured over four months. This helps understand how each treatment affects pain and function in MAS patients. The study monitors patient safety and treatment effects through these assessments.
CONDITIONS
Brief Title
Effectiveness of Serratus Posterior Superior Intercostal Plane Block Applied With Ultrasonography in Myofascial Pain Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 18 and 65 years old and diagnosed with Myofascial Pain Syndrome based on diagnostic criteria
- Have not had any invasive procedures for this condition in the last 3 months
- Be able to sign the informed consent form
- Have complete medical data available for review
You will not qualify if you...
- Having had an invasive procedure for Myofascial Pain Syndrome within the past 3 months
- Incomplete or missing medical data in patient files
- Unable or unwilling to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Retrospective assessment at baseline and follow-ups
Participants diagnosed with Myofascial Pain Syndrome have their medical data reviewed including pain and disability scores.
Duration - Single session
Participants undergo a single session of Serratus Posterior Superior Intercostal Plane Block or trigger point injection applied to the neck-back region.
1 visit (in-person)
Duration - Up to 4 months
Participants' pain levels and functional status are monitored through medical records for up to 4 months after the intervention.
Assessments at 1 and 3 months after treatment
Trial Site Locations
Total: 1 location
1
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye), 34000
Actively Recruiting
Research Team
H
halil ibrahim altun
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here